Real-world safety and clinical outcomes of cluster subcutaneous immunotherapy with olive pollen extracts, with or without grass pollen, in patients with allergic rhinoconjunctivitis and/or asthma
Information is provided on the safety profile and clinical outcomes observed in patients receiving depot allergoid SCIT administered in a cluster schedule in patients sensitized to Olea europaea pollen under routine clinical practice conditions.